Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lazar

Showing results (11-20 of 561) with videos related to

Pageof 57
Sort By:
Diabetes Care|November 1, 1980
Evaluating a learning device for juvenile diabetic childrenJ V Heston, S J Lazar
The American Journal of Cardiology|November 6, 1990
Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockadeW H Frishman, E J Lazar
Journal of Cardiovascular Pharmacology|January 1, 1988
Calcium channel blockers in patients with both hypertension and angina pectorisW H Frishman, E J Lazar
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 1974
Proceedings: Demonstration of the in vivo action of pepstatin: effects on plasma angiotensin II concentration (PAC)P Oster, J Lazar, E Hackenthal
Surgical Pathology Clinics|February 4, 2016
Nevoid MelanomaA Hafeez Diwan, Alexander J Lazar
Annals of Surgery|February 25, 2026
Unentrustable Professional Activities: Innovating Backwards with Robotics in Surgical TrainingDamien J Lazar, George S Ferzli
Surgery Open Science|April 10, 2024
Is the robotic revolution stunting surgical skills?Damien J Lazar, George S Ferzli
Clinics in Laboratory Medicine|May 10, 2011
Nevoid melanomaA Hafeez Diwan, Alexander J Lazar
Seminars in Oncology|November 8, 2011
Clinicopathologic considerations: how can we fine tune our approach to sarcoma?Elizabeth G Demicco, Alexander J Lazar
Science (New York, N.Y.)|February 11, 1972
Inhibition of the renin-angiotensinogen reaction by pepstatinF Gross, J Lazar, H Orth
Pageof 57

Showing results (11-20 of 561) with videos related to

Sort By:
Pageof 57
Diabetes Care|November 1, 1980
Evaluating a learning device for juvenile diabetic childrenJ V Heston, S J Lazar
The American Journal of Cardiology|November 6, 1990
Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockadeW H Frishman, E J Lazar
Journal of Cardiovascular Pharmacology|January 1, 1988
Calcium channel blockers in patients with both hypertension and angina pectorisW H Frishman, E J Lazar
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 1974
Proceedings: Demonstration of the in vivo action of pepstatin: effects on plasma angiotensin II concentration (PAC)P Oster, J Lazar, E Hackenthal
Surgical Pathology Clinics|February 4, 2016
Nevoid MelanomaA Hafeez Diwan, Alexander J Lazar
Annals of Surgery|February 25, 2026
Unentrustable Professional Activities: Innovating Backwards with Robotics in Surgical TrainingDamien J Lazar, George S Ferzli
Surgery Open Science|April 10, 2024
Is the robotic revolution stunting surgical skills?Damien J Lazar, George S Ferzli
Clinics in Laboratory Medicine|May 10, 2011
Nevoid melanomaA Hafeez Diwan, Alexander J Lazar
Seminars in Oncology|November 8, 2011
Clinicopathologic considerations: how can we fine tune our approach to sarcoma?Elizabeth G Demicco, Alexander J Lazar
Science (New York, N.Y.)|February 11, 1972
Inhibition of the renin-angiotensinogen reaction by pepstatinF Gross, J Lazar, H Orth
Pageof 57